𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effect of different neuroleptics in tardive dyskinesia and parkinsonism

Publisher
Springer
Year
1986
Tongue
English
Weight
709 KB
Volume
90
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.

✦ Synopsis

A video-controlled multicenter study with 0 chlorprothixene, perphenazine, haloperidol and haloperidol + biperiden

Nordic Dyskinesia Study Group

The Nordic Dyskinesia Study Group consists of the following: Participating centers.

πŸ“œ SIMILAR VOLUMES

Fluperlapine in tardive dyskinesia and p
Fluperlapine in tardive dyskinesia and parkinsonism
✍ SΓΈren Korsgaard; Ulla Noring; Jes Gerlach πŸ“‚ Article πŸ“… 1984 πŸ› Springer 🌐 English βš– 463 KB

Fluperlapine, a new clozapine-like neuroleptic drug with weak affinity for dopamine receptors, was evaluated in a blind, placebo controlled trial in 11 patients with stable hyperkinesia (ten with tardive dyskinesia (TD) and one with spontaneous dyskinesia). Drug effects during active treatment (200-

Parkinsonism and tardive dyskinesia afte
Parkinsonism and tardive dyskinesia after chronic use of clebopride
✍ A. P. Sempere; J. Duarte; J. M. Palomares; F. Coria; L. E. ClaverΓ­a πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 234 KB

Victor M, Adams RD, Cole M. The acquired (non-Wilsonian) type of chronic hepatocerebral degeneration.

Effect of a cholinomimetric drug (RS 86)
Effect of a cholinomimetric drug (RS 86) in tardive dyskinesia and drug-related parkinsonism
✍ U. Noring; U. Juul Povlsen; D. E. Casey; J. Gerlach πŸ“‚ Article πŸ“… 1984 πŸ› Springer 🌐 English βš– 241 KB

RS 86, a specific muscarinic agonist, was evaluated in a blind, placebo-controlled, single-dose trial in 10 psychiatric patients with stable tardive dyskinesia (TD). RS 86, 0.5-4 mg orally, produced no significant effects in TD, although 4 mg caused a minimal aggravation in parkinsonism. Side effect

Biphasic and long-lasting effect of ceru
Biphasic and long-lasting effect of ceruletide on tardive dyskinesia
✍ Tadashi Nishikawa; Masatoshi Tanaka; Itsuyuki Koga; Yasunori Uchida πŸ“‚ Article πŸ“… 1985 πŸ› Springer 🌐 English βš– 152 KB

A 55-year-old schizophrenic inpatient with buccolingual dyskinesia was treated with a single dose of ceruletide 0.8 gg/kg IM. Time-course effects of the drug were then followed for up to 6 weeks after injection. To assess changes in severity of bucco-lingual dyskinesia objectively, electromyogram (E